In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Moritz NiesertDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0003-2873-0032 Alexander FichtnerDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Georg F HoffmannDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0002-6593-896X Jürgen G OkunDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0003-2975-1054 Dóra PitukBruker Biospin GmbH, 76275 Ettlingen, Germany.
Christian GilleDepartment of Neonatology, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Johannes PöschlDepartment of Neonatology, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Sina WaldherrDepartment of Neonatology, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.
Andreas ZieglerDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0001-7574-1231 Jens H WesthoffDepartment of Pediatrics I, Center for Pediatrics and Adolescent Medicine, Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.ORCID 0000-0002-9837-9383 Funding
Dietmar Hopp Stiftung 1DH2011115
6 · The paper itselfAbstract
Very preterm infants with immature kidneys exhibit high vulnerability to acute kidney injury (AKI). While AKI is associated with adverse outcomes, serum-creatinine-based diagnostics prove unreliable in early risk assessment of kidney damage. This pilot study investigated
Indexed as
Acute Kidney InjuryDuctus Arteriosus, PatentInfant, Very Low Birth WeightMetabolomicsBiomarkersFemaleHumansIndomethacinInfant, NewbornMaleMetabolomePilot ProjectsBiomarkersIndomethacin1H-NMR-spectroscopyacute kidney injurybiomarkersmetabolomicsneonatologynephrologypreterm infants
Identifiers
PMID41897328
PMCPMC13024360
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390